Levine Leichtman Capital Partners (LLCP) has sold Therapeutic Research Center to Colibri Group, a portfolio company of Gridiron Capital.
Therapeutic Research Center (TRC) is a research, analytic, and information services company that provides evidence-based drug therapy and medication management recommendations to healthcare professionals and institutions including pharmacists, pharmacy technicians, prescribers, and nurses. TRC’s company owned brands and products include Pharmacist’s Letter, Pharmacy Technician’s Letter, Prescriber Insights, NetCE, NatMed Pro, CriticalPoint, Pharmacy Technicians University, RxSelect, RxAdvanced, Bula, and QURE.
Since its founding in 1985, TRC has served more than one million healthcare professionals and nearly four thousand hospitals. The company, acquired by LLCP in September 2017 through its fifth fund, is led by CEO Wes Crews and is headquartered in Denver.
“We are grateful for LLCP’s support and guidance as their strategic insights and partnership approach contributed greatly to the transformation of TRC,” said Mr. Crews. “Together, we have realized our shared vision of helping clinicians operate at the top of their license and improve clinical outcomes, thereby unlocking tremendous value for all stakeholders. LLCP’s contributions will continue to be instrumental as we enter our next phase of growth.”
“We are proud to have supported TRC and its management team in building a market leading, clinician-centric training platform to solve healthcare’s critical workforce challenges. During our investment, TRC made significant investments to strengthen TRC’s leadership team, commercial operations, and new product development function, while also successfully completing four highly strategic acquisitions that greatly expanded our clinician base and bolstered our suite of product offerings,” said Matthew Rich, a partner at LLCP. “The business is well positioned for continued growth, and we wish Wes and the entire management team continued success in their next chapter with Colibri.”


“We are proud of the collaboration between the Colibri and Gridiron teams to achieve this strategic milestone and are excited to welcome TRC to the team,” added Kevin Jackson, a managing partner at Gridiron.
In tandem with the acquisition of TRC, NB Capital Solutions acquired a minority stake in Colibri with Gridiron retaining a majority stake in Colibri.


LLCP invests in US and Europe-based middle-market companies across numerous industries including franchising, business services, education, engineered products, healthcare, and light manufacturing. Since its founding in 1984 by Arthur Levine and Lauren Leichtman, LLCP has managed $14.1 billion of institutional capital across 15 investment funds and has invested in over 100 portfolio companies. LLCP currently has $9.3 billion of assets under management with offices in Los Angeles, New York, Chicago, Charlotte, Miami, London, Stockholm, The Hague and Frankfurt.
Morgan Stanley & Co. was the lead financial advisor to TRC with support from William Blair & Company and Deloitte Corporate Finance.
Houlihan Lokey served as Colibri and Gridiron’s financial advisor and its exclusive placement agent in the purchase of TRC.
© 2023 Private Equity Professional | November 29, 2023
